Mark Lew, MD
Disclosures: Advisor-Acorda Therapeutics|Advisor-Neurocrine|Advisor-Supernus|Advisor-UCB|Advisor-Global Kinetics|Advisor-Kyowa Kirin|Advisor-Amneal|Grant or research support-Michael J. Fox Foundation|Grant or research support-Neuraly|Grant or research support-NIAA|Grant or research support-Jazz Pharmaceuticals|Grant or research support-UCB|Grant or research support-Inhibikase Therapeutics|Grant or research support-Biogen|Grant or research support-Ono Pharma|Other: Foundation Support-Michael J. Fox Foundation|Other: Foundation Support-Anenberg Foundation - 11/16/2023

Mark F. Lew, MD, received his medical degree from George Washington University in Washington DC, where he also served his Internship in Internal Medicine. He completed his Residency in Neurology at Los Angeles County+University of Southern California Medical Center and his Fellowship in Movement Disorders at the University of Southern California in Los Angeles. He is a Fellow of the American Academy of Neurology (FAAN), American Neurologic Association (FANA) and International Association of Parkinsonism and Related Disorders (FIAPRD) and holds Board Certification from the American Board of Psychiatry and Neurology (ABPN).

 

Dr. Lew joined the faculty of the Keck School of Medicine of the University of Southern California in 1991, where he now holds the position of Professor of Neurology,  Director of the Division of Movement Disorders as well as the Co- Director of the Anenberg Center for Biomarkers in Parkinson’s Disease and other Neurodegenerative Disorders. At present, he is also the Director of the Movement Disorders Clinic at Los Angeles County+University of Southern California Medical Center. He also holds the Joseph P. Van Der Meulen Chair in Parkinson’s Disease Research in honor of Robert  Pasarow.

 

Dr. Lew is currently focusing his research efforts in developing new tear-based bio-markers for Parkinson’s disease and other neurodegenerative disorders. He is also investigating new pharmacologic treatments for Parkinson's disease and dystonia. He is a Participating Scientist of both the Parkinson's Study Group and the Dystonia Study Group and is on the Medical Advisory Committee of the Musicians with Dystonia Program. He has also directed the dystonia clinic at the USC/LACH since 1991.

 

He is an author on more than 135 peer reviewed articles on PD, dystonia and other movement disorders. He has served on the Board of Directors of the USC-CRO and as a member of the Center for Human Studies Leadership Group for the USC CTSI. He served as the Vice Chairman in the Department of Neurology from 2004 - 2022.

 

He has served as a member of  the Editorial board of Parkinson’s Disease and Related Disorders. He is an ad hoc reviewer for Neurology, JNNP, International Journal of Neuroscience, Movement Disorders and Movement Disorders Clinical Practice. In addition, his own original clinical and research articles and abstracts have been published in such prestigious journals as JAMA, Science, Movement Disorders, Neurology, Annals of Neurology, American Journal of Psychiatry, Archives of Neurology, Journal of the American Geriatrics Society, Expert Reviews in Neurotherapeutics, Issues in Law and Medicine, Neurosurgery, Human Brain Mapping, American Journal of Human Genetics, Clinical Journal of Pain, Clinical Neuropharmacology, Neurologic Clinics, Neurobiology of Aging, Current Medical Research and Opinion, Pharmacotherapy, Journal of Neurological Sciences, and  Expert Review of Neurotherapeutics, Human Genetics, International Journal of Neuroscience and Parkinsonism and Related Disorders, International Journal of Neuroscience, Tremor and Hyperkinetic Movements, The Journal of Clinical Neurosciences ,the Journal of Neurotransmission,  and Biomarkers in Medicine.